In early 2025, investors saw indications that U.S. equity dominance was wavering. Now, the market volatility following the back-and-forth of U.S. tariffs is giving investors even more reason to take a fresh look at global equity strategies and rethink assumptions in their portfolios. It’s important to note that the current tariff-led disruption is not a blip; it is the latest signal in a multiyear trend of evolving global trading patterns and tariffs. This presents risks and opportunities and underscores the importance of active management in global equity strategies.
May 29, 2025
KEY TAKEAWAYS
- An opportunity presents itself for active investors who can find global companies less likely to be affected by tariffs.
- Multinationals may have a competitive advantage in the long term.
- Global market emphasis appears to be shifting away from mega-cap U.S. equities.
Change brings opportunity for active investors
In this environment, investors may want to put individual company and sector positions under the microscope. For example, tariffs were levied quickly on commoditized heavy industries such as metals and autos, weighing on companies in or adjacent to those industries. Conversely, there may be less impact in growth sectors like biopharma and semiconductor equipment, where some companies operate with limited competition. Those that provide essential products to the U.S. — such as patented drugs and specialized semiconductors and semiconductor-making equipment — also may be less affected if their products cannot easily be replaced by U.S. producers.
To be sure, the impact of tariffs could vary substantially, even within the same industry and country of domicile. Certain companies may also be more affected by tariffs than others based on the locations of their supply chains and customers.
“For the moment, local companies are out of the eye of the storm, but in the long run, the globally diversified multinational companies have the most flexibility,” says New Perspective Fund® equity portfolio manager Jody Jonsson.
These multinationals have the resources to respond to local-market consumer preferences and regulatory regimes, even as they enjoy economies of scale, diversified customer bases and global brand recognition. Pharmaceutical companies Novo Nordisk and AstraZeneca, based in Denmark and the U.K., respectively, are good examples. They are expanding research and manufacturing operations in the U.S., which could help reduce their exposure to U.S. tariffs.
But global trade developments are not the only source of potential opportunities. Equity valuations, for instance, clearly point to opportunities outside the U.S. market. Non-U.S. stocks carry far lower multiples than U.S.-based competitors, offering a broad set of attractively priced equities to then assess through the lens of tariffs.
Valuation gap — U.S. vs. rest of the world
Source: RIMES. As of March 31, 2025. Data reflect price-to-earnings ratios based on future earnings expectations. Calculations are based on the MSCI Emerging Markets Index, MSCI All Country World Index ex USA, MSCI Europe Index, MSCI Pacific Index and MSCI USA Index, respectively.
A potential decline in U.S. market concentration may also create fresh opportunities for investors. The Magnificent 7 stocks that have driven U.S. equity market gains in recent years are the latest in a string of once impregnable market leaders that includes technology stocks in the 1990s, Japanese stocks in the 1980s and the “Nifty Fifty” growth stocks that dominated U.S. markets in the early 1970s.
A pullback in the Magnificent 7 could lead to gains in a broader swath of large-cap companies. As shown below, several dozen companies whose market caps collectively equaled the Magnificent 7’s market caps generated significantly higher sales and profits. This highlights another large and diverse opportunity set.
The largest companies dominate the U.S. market …
Sources: Capital Group, FactSet. Rest of largest 48 companies represent stocks following the Magnificent 7, ranked by market capitalization, with the above stocks topping the list. Sales are the net sales (or revenues) of the relevant items reported in the last 12 months. Profit is represented by the trailing 12-month operating profit. As of 3/31/25.
Earnings growth figures appear to support this trend. S&P 500 Index companies outside the Magnificent 7 have narrowed the growth gap with the Magnificent 7 since 2023. This could increase the likelihood that a larger swath of companies will contribute to equity market returns.
Mag 7 earnings growth converging with the rest of the S&P 500
Summary
The new U.S. administration has brought a renewed emphasis on restructuring global trade and other policies intended to rewire the U.S. economy. As these efforts take hold, multinational companies will be challenged to navigate a rapidly changing operating environment. For investors, the key will be to assess the growth prospects of multinationals and their ability to navigate evolving global trade patterns, regardless of their geographies.
For an actively managed global equity portfolio that takes into consideration these fluctuating tariff landscapes and shifting dynamics, investors might consider New Perspective Fund, which is positioned for times like these. The fund seeks to take advantage of investment opportunities generated by changes in global trade patterns and economic and political relationships.